These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 1679342)

  • 21. Efficacy of triple DMARD therapy in patients with RA with suboptimal response to methotrexate.
    O'Dell JR; Haire C; Erikson N; Drymalski W; Palmer W; Maloley P; Klassen LW; Wees S; Moore GF
    J Rheumatol Suppl; 1996 Mar; 44():72-4. PubMed ID: 8833058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological management of juvenile rheumatoid arthritis.
    Rose CD; Doughty RA
    Drugs; 1992 Jun; 43(6):849-63. PubMed ID: 1379157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
    Schnabel A; Gross WL
    Dtsch Med Wochenschr; 2003 Jan; 128(4):147-9. PubMed ID: 12589584
    [No Abstract]   [Full Text] [Related]  

  • 24. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.
    Ranganath VK; Furst DE
    Clin Geriatr Med; 2005 Aug; 21(3):649-69, viii. PubMed ID: 15911212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.
    van Vollenhoven RF; Ernestam S; Geborek P; Petersson IF; Cöster L; Waltbrand E; Zickert A; Theander J; Thörner A; Hellström H; Teleman A; Dackhammar C; Akre F; Forslind K; Ljung L; Oding R; Chatzidionysiou A; Wörnert M; Bratt J
    Lancet; 2009 Aug; 374(9688):459-66. PubMed ID: 19665644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial. On behalf of the Rheumatic Research Foundation Utrecht, The Netherlands.
    van Jaarsveld CH; Jacobs JW; van der Veen MJ; Blaauw AA; Kruize AA; Hofman DM; Brus HL; van Albada-Kuipers GA; Heurkens AH; ter Borg EJ; Haanen HC; van Booma-Frankfort C; Schenk Y; Bijlsma JW
    Ann Rheum Dis; 2000 Jun; 59(6):468-77. PubMed ID: 10834865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 1989 Jun; 31(795):61-4. PubMed ID: 2567489
    [No Abstract]   [Full Text] [Related]  

  • 29. Sulfasalazine treatment for rheumatoid arthritis: a metaanalysis of 15 randomized trials.
    Weinblatt ME; Reda D; Henderson W; Giobbie-Hurder A; Williams D; Diani A; Docsa S
    J Rheumatol; 1999 Oct; 26(10):2123-30. PubMed ID: 10529127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis.
    Singh G; Fries JF; Williams CA; Zatarain E; Spitz P; Bloch DA
    J Rheumatol; 1991 Feb; 18(2):188-94. PubMed ID: 1673721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination therapy with disease modifying anti-rheumatic drugs in rheumatoid arthritis.
    Garrood T; Scott DL
    BioDrugs; 2001; 15(8):543-61. PubMed ID: 11543695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disease-modifying antirheumatic drugs.
    Ryan L; Brooks P
    Curr Opin Rheumatol; 1999 May; 11(3):161-6. PubMed ID: 10328573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The combination of methotrexate, sulfasalazine and hydroxychloroquine is highly effective in rheumatoid arthritis.
    Furst DE
    Clin Exp Rheumatol; 1999; 17(1):39-40. PubMed ID: 10084027
    [No Abstract]   [Full Text] [Related]  

  • 34. Variability in individual responses of 532 patients with rheumatoid arthritis to first-line and second-line drugs.
    Pincus T; Callahan LF
    Agents Actions Suppl; 1993; 44():67-75. PubMed ID: 8103964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of disease-modifying antirheumatic drugs versus cytotoxic agents in the therapy of rheumatoid arthritis.
    Ward JR
    Am J Med; 1988 Oct; 85(4A):39-44. PubMed ID: 3052055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rheumatoid arthritis--changing theories and treatment modalities.
    van de Putte LB; van Riel PL
    Acta Orthop Scand Suppl; 1995 Oct; 266():10-3. PubMed ID: 8553835
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of anti-malarials in rheumatoid arthritis--the American experience.
    Khraishi MM; Singh G
    Lupus; 1996 Jun; 5 Suppl 1():S41-4. PubMed ID: 8803910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapies for active rheumatoid arthritis after methotrexate failure.
    O'Dell JR; Mikuls TR; Taylor TH; Ahluwalia V; Brophy M; Warren SR; Lew RA; Cannella AC; Kunkel G; Phibbs CS; Anis AH; Leatherman S; Keystone E;
    N Engl J Med; 2013 Jul; 369(4):307-18. PubMed ID: 23755969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rheumatoid arthritis.
    Emery P; Suarez-Almazor M
    Clin Evid; 2003 Jun; (9):1349-71. PubMed ID: 15366179
    [No Abstract]   [Full Text] [Related]  

  • 40. [Combination therapy of rheumatoid arthritis].
    Hansen A; Jensen T
    Ugeskr Laeger; 1998 Sep; 160(40):5772-6. PubMed ID: 9782754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.